In Response

Affiliations

¹ Department of Anesthesia, Intensive Care and Pain Management, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
² Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt. hallasaad@yahoo.com.
³ Department of Cancer Biology (Pharmacology and Experimental Oncology), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
⁴ Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.
⁵ Department of Cancer Biology (Pharmacology and Experimental Oncology), National Cancer Institute, Cairo University, Cairo, Egypt.
⁶ Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
⁷ Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
⁸ Department of Pharmaceutics, Faculty of Pharmacy, Sphinx University, New Assiut City, Assiut, Egypt.
⁹ Assiut International Center of Nanomedicine, AL-Rajhy Liver Hospital, Assiut University, Assiut, Egypt.

Comment

Sahar Abdel-Baky Mohamed et al. Anesth Analg. 2022.

. 2022 Feb 1;134(2):e9-e11.

doi: 10.1213/ANE.0000000000005815.

¹ Department of Anesthesia, Intensive Care and Pain Management, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
² Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt. hallasaad@yahoo.com.
³ Department of Cancer Biology (Pharmacology and Experimental Oncology), South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
⁴ Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.
⁵ Department of Cancer Biology (Pharmacology and Experimental Oncology), National Cancer Institute, Cairo University, Cairo, Egypt.
⁶ Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
⁷ Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
⁸ Department of Pharmaceutics, Faculty of Pharmacy, Sphinx University, New Assiut City, Assiut, Egypt.
⁹ Assiut International Center of Nanomedicine, AL-Rajhy Liver Hospital, Assiut University, Assiut, Egypt.

No abstract available

Comment on

Pharmacokinetics and Pharmacodynamics of 3 Doses of Oral-Mucosal Dexmedetomidine Gel for Sedative Premedication in Women Undergoing Modified Radical Mastectomy for Breast Cancer.
Mohamed SA, Abdel-Ghaffar HS, Hassan NA, El Sherif FA, Shouman SA, Omran MM, Hassan SB, Allam AAAE, Sayed DG. Mohamed SA, et al. Anesth Analg. 2021 Feb 1;132(2):456-464. doi: 10.1213/ANE.0000000000005108. Anesth Analg. 2021. PMID: 32889844 Clinical Trial.
Pharmacokinetics Police.
Fisher DM, Shafer SL. Fisher DM, et al. Anesth Analg. 2022 Feb 1;134(2):e7-e8. doi: 10.1213/ANE.0000000000005813. Anesth Analg. 2022. PMID: 35030129 No abstract available.

1. Fisher DM, Shafer SL. Pharmacokinetics police. Anesth Analg. 2022;134:e7–e8.
1. Mohamed SA, Abdel-Ghaffar HS, Hassan NA, et al. Pharmacokinetics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer. Anesth Analg. 2021;132:456–464.
1. Anttila M, Penttilä J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol. 2003;56:691–693.
1. Fan J, de Lannoy IA. Pharmacokinetics. Biochem Pharmacol. 2014;87:93–120.
1. Gabrielsson J, Weiner D. Non-compartmental analysis. Methods Mol Biol. 2012;929:377–389.